Atossa Therapeutics, Inc. (ATOS) - Stock Prices, Stock Peers & Analysis

Home
ATOS

Company Name	Atossa Therapeutics, Inc.
Symbol	ATOS
Currency	USD
Price	1.33
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	167,256,810
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.62 - 2.31
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Steven C. Quay FCAP, M.D., Ph.D.
Website	https://www.atossatherapeutics.com

An error occurred while fetching data.

About Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also